Tukysa + Standard Tx Reduces Brain Lesion Growth in HER2+ MBC

Options
Moderators
Moderators Member Posts: 25,912
edited June 2020 in Stage IV/Metastatic Breast Cancer, Open to All To Contribute

Have you been diagnosed with metastatic HER2-positive breast cancer that has spread to the brain? A study found that adding Tukysa to standard treatment improved survival and reduced the risk that the brain lesions would grow.

Read Adding Tukysa to Standard Treatment Reduces Brain Lesion Growth Risk in HER2-Positive Metastatic Breast Cancer
· Share on FacebookShare on Twitter

Categories